S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
US Dollar Replaced By "Biden Bucks"? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
US Dollar Replaced By "Biden Bucks"? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
US Dollar Replaced By "Biden Bucks"? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
US Dollar Replaced By "Biden Bucks"? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
US Dollar Replaced By "Biden Bucks"? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
US Dollar Replaced By "Biden Bucks"? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
US Dollar Replaced By "Biden Bucks"? (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
US Dollar Replaced By "Biden Bucks"? (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
US Dollar Replaced By "Biden Bucks"? (Ad)
NASDAQ:BRKR

Bruker - BRKR Stock Forecast, Price & News

$62.16
-0.32 (-0.51%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$61.61
$62.77
50-Day Range
$59.28
$69.04
52-Week Range
$55.80
$92.35
Volume
919,583 shs
Average Volume
784,385 shs
Market Capitalization
$9.28 billion
P/E Ratio
34.34
Dividend Yield
0.32%
Price Target
$78.33

Bruker MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
26.0% Upside
$78.33 Price Target
Short Interest
Healthy
2.32% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.48
Upright™ Environmental Score
News Sentiment
0.21mentions of Bruker in the last 14 days
Based on 19 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.23%
From $2.29 to $2.57 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.97 out of 5 stars

Computer And Technology Sector

46th out of 833 stocks

Analytical Instruments Industry

3rd out of 35 stocks

BRKR stock logo

About Bruker (NASDAQ:BRKR) Stock

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Bruker Stock Performance

Shares of NASDAQ:BRKR opened at $62.16 on Tuesday. The stock has a fifty day moving average price of $63.49 and a two-hundred day moving average price of $64.01. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.62 and a current ratio of 2.55. The firm has a market cap of $9.28 billion, a P/E ratio of 34.34, a PEG ratio of 1.61 and a beta of 1.18. Bruker has a 1 year low of $55.80 and a 1 year high of $92.35.

Bruker (NASDAQ:BRKR - Get Rating) last issued its quarterly earnings results on Wednesday, August 3rd. The medical research company reported $0.45 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.45. Bruker had a return on equity of 31.36% and a net margin of 11.06%. During the same quarter last year, the company posted $0.44 earnings per share. Research analysts forecast that Bruker will post 2.29 EPS for the current fiscal year.

Bruker Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, June 17th. Shareholders of record on Wednesday, June 1st were paid a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date was Tuesday, May 31st. Bruker's payout ratio is currently 11.05%.

Analyst Upgrades and Downgrades

BRKR has been the topic of several analyst reports. StockNews.com cut Bruker from a "strong-buy" rating to a "buy" rating in a research report on Saturday, July 16th. The Goldman Sachs Group lowered their target price on Bruker from $73.00 to $60.00 and set a "sell" rating on the stock in a research report on Wednesday, April 13th.

Receive BRKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.

BRKR Stock News Headlines

Bruker: Q2 Earnings Snapshot - Greenwich Time
Bruker (BRKR) Meets Q2 Earnings Estimates
Bruker Reports Second Quarter 2022 Financial Results
Bruker (NASDAQ:BRKR) Rating Lowered to Buy at StockNews.com
See More Headlines
Receive BRKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.

BRKR Company Calendar

Ex-Dividend for 6/17 Dividend
5/31/2022
Dividend Payable
6/17/2022
Last Earnings
8/03/2022
Today
8/09/2022
Next Earnings (Estimated)
11/07/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:BRKR
CUSIP
11679410
Employees
7,765
Year Founded
1960

Price Target and Rating

Average Stock Price Forecast
$78.33
High Stock Price Forecast
$90.00
Low Stock Price Forecast
$60.00
Forecasted Upside/Downside
+26.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$277.10 million
Pretax Margin
15.83%

Debt

Sales & Book Value

Annual Sales
$2.42 billion
Cash Flow
$2.69 per share
Book Value
$7.15 per share

Miscellaneous

Free Float
108,061,000
Market Cap
$9.28 billion
Optionable
Optionable
Beta
1.18

Social Links


Key Executives

  • Dr. Frank H. Laukien Ph.D. (Age 62)
    Chairman, CEO & Pres
    Comp: $2.44M
  • Mr. Gerald N. Herman (Age 64)
    Exec. VP & CFO
    Comp: $1.08M
  • Dr. Mark R. Munch Ph.D. (Age 60)
    Corp. Exec. VP and Pres of Bruker Nano Group & Corp.
    Comp: $1.54M
  • Mr. Juergen Srega (Age 67)
    Pres of Bruker CALID Group & Bruker Daltonics Division
    Comp: $960.8k
  • Dr. Falko Busse Ph.D. (Age 55)
    Pres of Bruker BioSpin Group
    Comp: $738.54k
  • Mr. Justin Joseph Ward
    Sr. Director of Investor Relations & Corp. Devel.
  • Mr. J. Brent Alldredge J.D. (Age 47)
    Gen. Counsel
  • Mr. Collin J. D'Silva (Age 65)
    Pres of Chemical Analysis Division
  • Stacey Desrochers
    Treasurer & Director of Investor Relations
  • Mr. Urban Faeh
    Pres of Bruker Optics Division & Managing Director of Bruker Optik GmbH













BRKR Stock - Frequently Asked Questions

Should I buy or sell Bruker stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BRKR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BRKR, but not buy additional shares or sell existing shares.
View BRKR analyst ratings
or view top-rated stocks.

What is Bruker's stock price forecast for 2022?

3 analysts have issued 1 year target prices for Bruker's shares. Their BRKR share price forecasts range from $60.00 to $90.00. On average, they expect the company's stock price to reach $78.33 in the next twelve months. This suggests a possible upside of 26.0% from the stock's current price.
View analysts price targets for BRKR
or view top-rated stocks among Wall Street analysts.

How has Bruker's stock price performed in 2022?

Bruker's stock was trading at $83.91 at the beginning of the year. Since then, BRKR shares have decreased by 25.9% and is now trading at $62.16.
View the best growth stocks for 2022 here
.

When is Bruker's next earnings date?

Bruker is scheduled to release its next quarterly earnings announcement on Monday, November 7th 2022.
View our BRKR earnings forecast
.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) announced its quarterly earnings data on Wednesday, August, 3rd. The medical research company reported $0.45 EPS for the quarter, hitting the consensus estimate of $0.45. Bruker had a net margin of 11.06% and a trailing twelve-month return on equity of 31.36%. During the same quarter in the previous year, the company earned $0.44 EPS.

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Monday, May 16th. Shareholders of record on Wednesday, June 1st will be paid a dividend of $0.05 per share on Friday, June 17th. This represents a $0.20 annualized dividend and a yield of 0.32%. The ex-dividend date is Tuesday, May 31st.
Read our dividend analysis for BRKR
.

Is Bruker a good dividend stock?

Bruker (NASDAQ:BRKR) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.32%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 11.05%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BRKR will have a dividend payout ratio of 7.78% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BRKR.

What guidance has Bruker issued on next quarter's earnings?

Bruker updated its FY22 earnings guidance on Wednesday, August, 3rd. The company provided earnings per share guidance of $2.29-2.33 for the period, compared to the consensus earnings per share estimate of $2.29. The company issued revenue guidance of ~$2.48-2.53 billion, compared to the consensus revenue estimate of $2.55 billion.

What is Frank H. Laukien's approval rating as Bruker's CEO?

126 employees have rated Bruker Chief Executive Officer Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among the company's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 79.0% of employees surveyed would recommend working at Bruker to a friend.

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Who are Bruker's major shareholders?

Bruker's stock is owned by a number of retail and institutional investors. Top institutional shareholders include TD Asset Management Inc. (1.11%), Brown Advisory Inc. (0.93%), Candriam S.C.A. (0.28%), Sector Gamma AS (0.17%), Ceredex Value Advisors LLC (0.10%) and Retirement Systems of Alabama (0.09%). Insiders that own company stock include Burkhard Prause, Cynthia M Friend, Frank H Laukien, Marc A Kastner and Mark Munch.
View institutional ownership trends
.

How do I buy shares of Bruker?

Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $62.16.

How much money does Bruker make?

Bruker (NASDAQ:BRKR) has a market capitalization of $9.28 billion and generates $2.42 billion in revenue each year. The medical research company earns $277.10 million in net income (profit) each year or $1.81 on an earnings per share basis.

How many employees does Bruker have?

Bruker employs 7,765 workers across the globe.

Does Bruker have any subsidiaries?

The following companies are subsidiares of Bruker: Accel Instruments, Advances Diagnostic Solutions Pty. Ltd., Agapetus GmbH, Alicona Corporation, Alicona GmbH, Alicona Imaging, Alicona Imaging GmbH, Alicona Korea Pcific Ltd., Alicona Manufacturing Inc., Alicona SARL, Alicona UK Limited, Alicona s.r.l., Anasys Instruments Corporation, Anasys Instruments GmbH, Arxspan, Biocentra AS., Bruker (Beijing) Scientific Technology Co. Ltd., Bruker (Malaysia) SDN BHD, Bruker AXS GmbH, Bruker AXS Handheld Inc., Bruker AXS LLC, Bruker AXS Ltd., Bruker Advanced Supercon GmbH, Bruker Austria GmbH, Bruker Belgium S.A./N.V., Bruker BioSciences Securities Corporation, Bruker BioSpin AG, Bruker BioSpin Corporation, Bruker BioSpin GmbH, Bruker BioSpin K.K., Bruker BioSpin MRI GmbH, Bruker Business Support Center sp. z o.o, Bruker Daltonics GmbH, Bruker Daltonics Ltd., Bruker Daltonics Pty. Ltd., Bruker Daltonics S.r.l., Bruker Daltonik GmbH, Bruker Detection Corporation, Bruker EAS GmbH, Bruker Energy & Supercon Technologies Inc. , Bruker Espanola S.A., Bruker Finance B.V., Bruker France S.AS., Bruker HTS GmbH, Bruker India Scientific PVT Ltd., Bruker Invest AG, Bruker Italia S.r.l., Bruker JV Israel Ltd., Bruker JV UK Ltd., Bruker Korea Co. Ltd., Bruker Ltd., Bruker Mexicana S.A. de C.V., Bruker MicroCT N.V., Bruker Nano GmbH, Bruker Nano Inc., Bruker Nederland B.V., Bruker Nordic AB, Bruker OST LLC, Bruker Optics GmbH, Bruker Optics Inc. , Bruker Optik GmbH, Bruker PTY Ltd., Bruker Physik GmbH, Bruker Polska Sp. Z o.o., Bruker Portugal Unipessoal LDA, Bruker Scientific Instruments Hong Kong Co. Ltd., Bruker Scientific Israel Ltd., Bruker Scientific LLC, Bruker Singapore Pte. Ltd., Bruker South Africa (Pty) Ltd., Bruker Taiwan Co. Ltd., Bruker Turkey Teknolojik Sistemler Ticaret Ltd. Sirketi, Bruker UK Ltd., Bruker do Brasil Ltda., Bruker s.r.o., Hain LifeScience E.A. Ltd., Hain LifeScience GmbH, Hain LifeScience Solutions (Pty) Ltd., Hain LifeScience Spain S.L., Hain LifeScience UK Ltd., Hain LifeSciences S.A. Pty Ltd., Hydrostatic Extrusions Ltd., Hysitron, InCoaTec GmbH, InVivo Biotech Services GmbH, InVivo Biotech Svs GmbH, JPK Instruments Limited, JPK Instruments USA. Inc., JPK In­stru­ments, JUWE Laborgeraete, Jordan Valley Semiconductors, Keymaster Technologies, Luxendo, Luxendo GmbH, MAC Science, Merlin Diagnostika GmbH, Mestrelab Research S.L., Michrom Bioresources, Oncovision - Innovative Medical Imaging, PMOD Technologies, Prairie Technologies, Princeton Gamma-Tech Instruments Inc, Quantron, RI Research Instruments GmbH, Roentec AG, S.I.S. Surface Imaging Systems, SAS Biocentric, SCiLS GmbH, SkyScan, Socabim, VACUUMSCHMELZE GmbH & Co. KG, Vutara LLC, XGLabs S.r.l., and Yingsheng Technology.
Read More

When was Bruker founded?

Bruker was founded in 1960.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The official website for the company is www.bruker.com. The medical research company can be reached via phone at (978) 663-3660, via email at investor.relations@bruker.com, or via fax at 978-663-5585.

This page (NASDAQ:BRKR) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.